John W. Kozarich - May 11, 2021 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Director
Signature
By: Charles S. Berkman For: John W. Kozarich
Stock symbol
LGND
Transactions as of
May 11, 2021
Transactions value $
-$1,337
Form type
4
Date filed
5/13/2021, 08:57 PM
Next filing
Jun 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Options Exercise $48.9K +4.84K +16.28% $10.12 34.5K May 11, 2021 Direct
transaction LGND Common Stock Tax liability -$50.3K -391 -1.13% $128.56 34.2K May 11, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LGND Non-Qualified Stock Option (right to buy) Options Exercise $0 -4.84K -100% $0.00* 0 May 11, 2021 Common Stock 4.84K $10.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the exercise price of options.
F2 Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 01, 2011, and fully vested on the first anniversary of the grant date.